EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical and patient‐reported outcomes of tissue engineering strategies for periodontal and peri‐implant reconstruction

Lorenzo Tavelli iD, Shayan Barootchi iD, Giulio Rasperini iD, William V Giannobile iD

Periodontology 2000 · 2023-02 · 91 (1) · 217-269

DOI: 10.1111/prd.12446 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Periodontology 2000, online erschienen am 27.09.2022. Verfasst von Lorenzo Tavelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Periodontology, Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Tissue Engineering, Sinus Floor Augmentation. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, Delta Dental Foundation, National Institute of Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scientific advancements in biomaterials, cellular therapies, and growth factors have brought new therapeutic options for periodontal and peri‐implant reconstructive procedures. These tissue engineering strategies involve the enrichment of scaffolds with living cells or signaling molecules and aim at mimicking the cascades of wound healing events and the clinical outcomes of conventional autogenous grafts, without the need for donor tissue. Several tissue engineering strategies have been explored over the years for a variety of clinical scenarios, including periodontal regeneration, treatment of gingival recessions/mucogingival conditions, alveolar ridge preservation, bone augmentation procedures, sinus floor elevation, and peri‐implant bone regeneration therapies. The goal of this article was to review the tissue engineering strategies that have been performed for periodontal and peri‐implant reconstruction and implant site development, and to evaluate their safety, invasiveness, efficacy, and patient‐reported outcomes. A detailed systematic search was conducted to identify eligible randomized controlled trials reporting the outcomes of tissue engineering strategies utilized for the aforementioned indications. A total of 128 trials were ultimately included in this review for a detailed qualitative analysis. Commonly performed tissue engineering strategies involved scaffolds enriched with mesenchymal or somatic cells (cell‐based tissue engineering strategies), or more often scaffolds loaded with signaling molecules/growth factors (signaling molecule‐based tissue engineering strategies). These approaches were found to be safe when utilized for periodontal and peri‐implant reconstruction therapies and implant site development. Tissue engineering strategies demonstrated either similar or superior clinical outcomes than conventional approaches for the treatment of infrabony and furcation defects, alveolar ridge preservation, and sinus floor augmentation. Tissue engineering strategies can promote higher root coverage, keratinized tissue width, and gingival thickness gain than scaffolds alone can, and they can often obtain similar mean root coverage compared with autogenous grafts. There is some evidence suggesting that tissue engineering strategies can have a positive effect on patient morbidity, their preference, esthetics, and quality of life when utilized for the treatment of mucogingival deformities. Similarly, tissue engineering strategies can reduce the invasiveness and complications of autogenous graft‐based staged bone augmentation. More studies incorporating patient‐reported outcomes are needed to understand the cost‐benefits of tissue engineering strategies compared with traditional treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringSinus Floor AugmentationHumansQuality of LifeGingivaBiocompatible Materials

Stichwörter der Autor:innen

bone regenerationcell therapyevidence-based dentistrygingival recessiongrowth factorstissue engineering

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Division of Periodontology, Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • Center for Clinical Research and Evidence Synthesis in Oral Tissue Regeneration (CRITERION), Boston, Massachusetts, USA.
  • Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
  • IRCCS Foundation Polyclinic Ca' Granda, University of Milan, Milan, Italy.
  • Harvard School of Dental Medicine, Boston, Massachusetts, USA.

ORCID-Profile: Lorenzo Tavelli, Shayan Barootchi, Giulio Rasperini, William V Giannobile

Förderung

  • NIDCR NIH HHS
  • Delta Dental Foundation
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Tavelli, L., Barootchi, S., Rasperini, G., & Giannobile, W. V. (2023). Clinical and patient‐reported outcomes of tissue engineering strategies for periodontal and peri‐implant reconstruction. Periodontology 2000, 91(1), 217-269. https://doi.org/10.1111/prd.12446

Vancouver

Tavelli L, Barootchi S, Rasperini G, Giannobile WV. Clinical and patient‐reported outcomes of tissue engineering strategies for periodontal and peri‐implant reconstruction. Periodontology 2000. 2023;91(1):217-269. doi:10.1111/prd.12446

BibTeX
@article{Tavelli2023,
  author = {Tavelli, Lorenzo and Barootchi, Shayan and Rasperini, Giulio and Giannobile, William V},
  title = {Clinical and patient‐reported outcomes of tissue engineering strategies for periodontal and peri‐implant reconstruction},
  journal = {Periodontology 2000},
  year = {2023},
  volume = {91},
  number = {1},
  pages = {217--269},
  doi = {10.1111/prd.12446}
}
Kostenlos starten →